Table 3.
Variables | Models | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Model 1 | Model 2 | Model 3 | ||||||||
Anthropometric parameters | Quartiles | βb (95% CI) | P Value | P for Trend | βb (95% CI) | P Value | P for Trend | βb (95% CI) | P Value | P for Trend |
Normal range of serum phosphate | ||||||||||
Thigh Circumference | Q2 v.s. Q1 | −0.26(−0.69, 0.18) | 0.247 | <0.001 | 0.07(−0.13, 0.27) | 0.491 | <0.001 | 0.07(−0.13, 0.28) | 0.472 | <0.001 |
Q3 v.s. Q1 | −0.81(−1.26, −0.37) | <0.001 | −0.14(−0.35, 0.06) | 0.173 | −0.14(−0.35, 0.07) | 0.182 | ||||
Q4 v.s. Q1 | −1.00(−1.46, −0.54) | <0.001 | −0.32(−0.54, −0.10) | 0.004 | −0.31(−0.52, −0.09) | 0.006 | ||||
Calf Circumference | Q2 v.s. Q1 | −0.09(−0.36, 0.18) | 0.504 | <0.001 | −0.15(−0.01, 0.30) | 0.054 | 0.228 | 0.154(0.01, 0.31) | 0.047 | 0.278 |
Q3 v.s. Q1 | −0.47(−0.74, −0.19) | <0.001 | −0.03(−0.19, 0.13) | 0.703 | −0.03(−0.18, 0.13) | 0.730 | ||||
Q4 v.s. Q1 | −0.55(−0.83, −0.26) | <0.001 | −0.04(−0.21, 0.12) | 0.602 | −0.03(−0.20, 0.13) | 0.699 | ||||
Muscle Strength | Q2 v.s. Q1 | −7.66(−16.89, 1.57) | 0.104 | 0.033 | −7.08(−16.08, 1.92) | 0.123 | 0.034 | −6.48(−15.48, 2.52) | 0.158 | 0.035 |
Q3 v.s. Q1 | −9.62(−19.20, −0.04) | 0.049 | −8.90(−18.28, 0.47) | 0.063 | −8.47(−17.84, 0.89) | 0.076 | ||||
Q4 v.s. Q1 | −10.47(−20.92, −0.01) | 0.050 | −10.44(−20.71, −0.16) | 0.047 | −10.39(−20.66, −0.12) | 0.047 | ||||
Serum phosphate <0.81 | ||||||||||
Thigh Circumference | Q2 v.s. Q1 | −0.98 (−4.00, 2.05) | 0.525 | 0.626 | −1.68 (−4.62, 1.26) | 0.261 | 0.832 | −1.29 (−4.20, 1.61) | 0.380 | 0.932 |
Q3 v.s. Q1 | −2.47 (−5.42, 0.49) | 0.101 | −1.95 (−4.87, 0.98) | 0.191 | −1.47 (−4.31, 1.38) | 0.310 | ||||
Q4 v.s. Q1 | −0.42 (−3.06, 3.91) | 0.811 | 0.54 (−2.87, 3.94) | 0.756 | 0.58(−2.77, 3.93) | 0.732 | ||||
Calf Circumference | Q2 v.s. Q1 | −1.01 (−2.86, 0.85) | 0.284 | 0.635 | −1.49 (−3.31, 0.33) | 0.108 | 0.853 | −1.28 (−3.09, 0.53) | 0.164 | 0.746 |
Q3 v.s. Q1 | −0.96 (−2.76, 0.84) | 0.295 | −0.82 (−2.63, 0.98) | 0.369 | −0.75 (−2.52, 1.01) | 0.400 | ||||
Q4 v.s. Q1 | −0.27 (−2.34, 1.81) | 0.802 | −0.08 (−2.12, 1.96) | 0.936 | −0.24 (−2.25, 1.77) | 0.815 | ||||
Muscle Strength | Q2 v.s. Q1 | −5.53 (−87.62, 76.56) | 0.893 | 0.105 | −18.84 (−84.28, 46.61) | 0.566 | 0.811 | 7.16 (−65.29, 79.60) | 0.843 | 0.766 |
Q3 v.s. Q1 | −25.57(−109.07, 57.92) | 0.543 | 1.38 (−76.41, 79.17) | 0.972 | 38.16(−50.29, 126.61) | 0.390 | ||||
Q4 v.s. Q1 | −73.22(−162.02, 15.57) | 0.104 | −12.25(−81.21, 56.70) | 0.723 | 7.61(−66.99, 82.21) | 0.838 | ||||
Serum phosphate >1.49 | ||||||||||
Thigh Circumference | Q2 v.s. Q1 | 1.68 (−0.97, 4.34) | 0.213 | 0.462 | 2.16 (−0.33, 4.65) | 0.088 | 0.841 | 2.89 (0.35, 5.44) | 0.026 | 0.940 |
Q3 v.s. Q1 | 0.63 (−2.14, 3.41) | 0.653 | 1.34 (−1.22, 3.91) | 0.303 | 1.73 (−0.90, 4.37) | 0.196 | ||||
Q4 v.s. Q1 | −0.36 (−3.14, 2.43) | 0.802 | 0.32 (−2.36, 2.99) | 0.817 | 0.77 (−1.97, 3.50) | 0.582 | ||||
Calf Circumference | Q2 v.s. Q1 | 1.19 (−0.52, 2.90) | 0.170 | 0.479 | 1.29 (−0.36, 2.95) | 0.125 | 0.916 | 1.67 (−0.03, 3.37) | 0.054 | 0.842 |
Q3 v.s. Q1 | 0.45 (−1.34, 2.23) | 0.623 | 0.89 (−0.82, 2.59) | 0.306 | 1.08 (−0.67, 2.84) | 0.226 | ||||
Q4 v.s. Q1 | −0.19 (−1.98, 1.60) | 0.839 | 0.21 (−1.56, 1.98) | 0.817 | 0.26 (−1.56, 2.07) | 0.782 | ||||
Muscle Strength | Q2 v.s. Q1 | 30.27(−70.87, 131.41) | 0.549 | 0.274 | 1.52 (−72.89, 75.94) | 0.967 | 0.125 | 3.63 (−73.32, 80.58) | 0.923 | 0.054 |
Q3 v.s. Q1 | −60.00(−175.66, 55.66) | 0.301 | −73.21(−157.81, 11.39) | 0.087 | −58.70(−144.91, 27.50) | 0.173 | ||||
Q4 v.s. Q1 | −27.44(−143.10, 88.21) | 0.634 | −40.28(−121.61, 41.05) | 0.321 | −58.80(−142.86, 25.26) | 0.162 |
aAdjusted covariates:
Model 1 = Unadjusted.
Model 2 = Model 1 + age, sex, race/ethnicity + BMI, serum fasting glucose, serum cholesterol, AST, serum HDL, serum calcium, serum creatinine.
Model 3 = Model 2+ history of congestive heart failure, coronary heart disease, angina/angina pectoris, heart attack, stroke, smoking.
bβ coefficients was interpreted as change of telomere length for each increase in different anthropometric parameters.
Abbreviation: BMI, body mass index; SBP, systolic blood pressure; ALT, alanine aminotransferase.